MedPath

Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization

Not Applicable
Completed
Conditions
Uterine Cervical Dysplasia
Interventions
Procedure: Loop Excision Procedure
Procedure: Fischer Cone Biopsy Excisor
Registration Number
NCT02515162
Lead Sponsor
Zydolab - Institute of Cytology and Immune Cytochemistry
Brief Summary

In a randomized clinical trial of 160 women undergoing conization for cervical dysplasia, two electrosurgical excision methods, Fischer Cone Biopsy Excison vs. Loop Excision Procedure, will be compared. The primary outcome of the study is dysplasia-free resection margin rate, secondary outcomes are intraoperative blood loss, time to complete hemostasis, intervention time, postoperative pain, intra- and postoperative complications, the resected cone volume and users satisfaction.

Detailed Description

Conization is the method of choice in therapy for cervical dysplasia. Beside the risk of preterm delivery, the risk of a local relapse in patients with dysplasia-affected resection margin is high.

The Goldstandard standard technique in conization for women with cervical dysplasia is the large loop excision of the transformation zone ("LLETZ"). Nevertheless other techniques such as the excision of the abnormal tissue with the so called "Fischer Cone Biopsy Excisor" could provide advantages and is yet not enough investigated. The loop excision technique uses a circular electrode, in contrast Fischer Cone Biopsy Excision is done by a triangular electrode.

It is unknown, whether the use of the circular or the triangular electrode is superior regarding the dysplasia-free resection margin rate and other outcome parameters such as the resected cone volume, postoperative bleeding and postoperative pain. Therefore, the investigator designed a randomized clinical trial of 160 women undergoing conization for cervical dysplasia, comparing the two electrosurgical techniques, "LLETZ-conization" and "Fischer Cone Biopsy Excision". The primary outcome of the study is the dysplasia-free resection margin rate independently proved by a pathologist, secondary outcomes are intraoperative blood loss measured as difference in serum hemoglobin pre- and postoperatively, postoperative pain according to a 11 step VAS scale, time to complete hemostasis measured in seconds, duration of the intervention measured in minutes, resected cone volume, users satisfaction according to a 11 step VAS scale and intra- and postoperative complications, defined as necessity to intervene surgically up to 14 days postoperatively.

The study Population consists of women undergoing conization for histologically proven cervical dysplasia.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
178
Inclusion Criteria
  • histologically proven cervical dysplasia
  • colposcopy Prior to conization
  • informed consent
  • no known hematologic disorder
Exclusion Criteria
  • significant language barrier
  • a personal history of conization
  • pregnancy
  • the use of blood thinner
  • unwillingness to participate

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Loop Excision ProcedureLoop Excision ProcedureConization Methode using a circular electrode , i.e. Loop excision Procedure
Fischer Cone Biopsy ExcisorFischer Cone Biopsy ExcisorConization Methode using a triangular electrode , i.e. Fischer Cone Biopsy Excisor
Primary Outcome Measures
NameTimeMethod
Margin status2 Days after conization

Resection margin is judge as "R0" if abnormal cells are not found in the margin of the biopsy or "R1" if abnormal cells remain in the margin of the biopsy. The histopathological examination will be done by an Independent pathologist

Secondary Outcome Measures
NameTimeMethod
Intraoperative blood loss5 hours

intraoperative blood loss will be measured using the difference in serum hemoglobin one day prior to surgery and within 5 hours postoperatively

Postoperative pain5 hours

patients will score their postoperative pain Level using a 11-step visual analogue scale (nVAS) and a 5-step graphical visual analogue scale (gVAS)within 5 hours after surgery

Time to complete intraoperative hemostasis120 seconds

the time until complete hemostasis as judged by the surgeon has been achieved, will be measured in seconds

Operation time20 minutes

the time from the beginning of the Operation (start of the electrosurgical method) until the end of the operation (the end of hemostatic interventions) will be measured in minutes

Resected cone volume10 minutes

The resected cone volume will be measured postoperative by using a scale

satisfaction with the device30 minutes

surgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,satisfaction with the device' (ranging from 0 (,very satisfied') to 10 (,absolutely not satisfied')

handling of the device30 minutes

surgeons will score their preference regarding the surgical method using an 11-step visual analogue scale (VAS) for ,(ranging from 0 (,very easy') to 10 (,very difficult')

Operative complications14 days

Operative complications defined as necessity to intervene surgically up to 14 days postoperatively

number of fragments of the surgical specimen10 minutes

surgeons will count the number of the surgical specimen (1 vs. \>1)

Trial Locations

Locations (1)

Department of Obstetrics and Gynecology of the Ruhr University Bochum

🇩🇪

Herne, NRW, Germany

© Copyright 2025. All Rights Reserved by MedPath